Because mTORC1 promotes cell growth and proliferation and is aberrantly active in many cancers (Laplante and Sabatini, 2012), we hypothesized that oncogenic Apc mutations might activate mTORC1 independently of β-catenin, and that this activation is important for Apc mutant phenotypes. Here, APC is linked to cancer.